Results 211 to 220 of about 121,365 (288)

Angiography in Abdominal Trauma

open access: yesAnnals of Surgery, 1969
Stewart R. Reuter   +2 more
openaire   +4 more sources

Undetermined Ruptured Low-Grade Appendiceal Mucinous Neoplasm Following High-Energy Blunt Abdominal Trauma Requiring Emergency Laparotomy. [PDF]

open access: yesClin Case Rep
Matsuo I   +9 more
europepmc   +1 more source

Two Cases of Blunt Abdominal Trauma with CT Findings Mimicking those of Intraperitoneal Free Air: A Pitfall of High-Performance CT

open access: bronze, 2003
Yoshihiro Moriwaki   +6 more
openalex   +2 more sources

Interventional therapies for chronic heart failure: An overview of recent developments

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo   +7 more
wiley   +1 more source

Dapagliflozin alleviates high‐fat‐induced obesity cardiomyopathy by inhibiting ferroptosis

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1358-1373, April 2025.
Abstract Aim: Dapagliflozin (Dapa) is a novel hypoglycaemic agent with multiple cardiovascular protective effects, and it is widely used in treatment of heart failure patients, but whether it can improve obese phenotype of heart failure and its mechanism is still unclear.
Di Chen   +7 more
wiley   +1 more source

TWO CASES OF DELAYED STENOSIS OF THE SMALL BOWEL FOLLOWING ABDOMINAL BLUNT TRAUMA

open access: bronze, 2003
Toshihide Arai   +5 more
openalex   +2 more sources

Early administration of SGLT2 inhibitors in hospitalized patients: A practical guidance from the current evidence

open access: yesESC Heart Failure, EarlyView.
Abstract Sodium‐glucose cotransporter‐2 (SGLT2) inhibitors represent one of the main cornerstones of heart failure treatment. Nevertheless, while the cardiovascular beneficial effects of these drugs have been clearly demonstrated by several clinical trials, in clinical practice, it remains challenging to identify the appropriate timing to start SGLT2 ...
Ruggero Mazzotta   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy